- US-listed companies
- PROTHENA CORP PUBLIC LTD CO
PROTHENA CORP PUBLIC LTD COPRTA
Market cap
$1.9B
P/E ratio
Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | |
Collaboration revenue | - | - | - | - | - | - | - | 1 | 140 | 14 | 91 |
License | - | - | - | - | - | - | - | 0 | 61 | 40 | 0 |
Revenues | - | 51 | 2 | 1 | 28 | 1 | 1 | 1 | 201 | 54 | 91 |
Research and development | 26 | 38 | 58 | 120 | 135 | 101 | 51 | 75 | 82 | 136 | 221 |
General and administrative | 15 | 19 | 23 | 41 | 48 | 42 | 36 | 39 | 46 | 50 | 62 |
Total operating expenses | 41 | 58 | 82 | 161 | 183 | 160 | 87 | 114 | 129 | 185 | 282 |
Income (loss) from operations | -40 | -7 | -80 | -160 | -155 | -159 | -86 | -113 | 72 | -132 | -191 |
Interest income | - | - | - | 1 | -0 | 3 | 8 | 1 | 0 | 6 | 31 |
Other expense, net | -0 | 0 | -0 | 0 | -2 | 0 | 0 | -0 | -0 | -0 | -0 |
Total other income (expense), net | -0 | 0 | 0 | 1 | -2 | 3 | 8 | 1 | -0 | 6 | 31 |
Income (loss) before income taxes | -41 | -6 | -80 | -159 | -158 | -156 | -77 | -111 | 72 | -126 | -160 |
Income Tax Expense (Benefit) | 0 | 1 | 1 | 1 | -4 | -0 | 0 | -0 | 5 | -9 | -13 |
Net income (loss) | -41 | -7 | -81 | -160 | -153 | -156 | -78 | -111 | 67 | -117 | -147 |
Earnings Per Share, Basic | - | - | - | - | - | - | - | - | 1.51 | -2.47 | -2.76 |
Earnings Per Share, Diluted | - | - | - | - | - | - | - | - | 1.38 | -2.47 | -2.76 |